# Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors

> **NCT00978146** · PHASE2 · WITHDRAWN · sponsor: **Children's Hospital of Philadelphia**

## Conditions studied

- Desmoid Tumors
- Fibromatosis

## Interventions

- **DRUG:** Hydroxyurea

## Key facts

- **NCT ID:** NCT00978146
- **Lead sponsor:** Children's Hospital of Philadelphia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-10
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study was administratively withdrawn by the IRB; no subjects were enrolled
- **Last updated:** 2017-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00978146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00978146, "Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00978146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*